Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls

H. A. Guirgis; H. T. Lynch; T. Mate; R. E. Harris; I. Wells; L. Caha; J. Anderson; K. Maloney; L. Rankin

doi:10.1159/000225116

Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls

H. A. Guirgis, H. T. Lynch, T. Mate, R. E. Harris, I. Wells, L. Caha, J. Anderson, K. Maloney, L. Rankin

Department of Preventive Medicine

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Abstract

A radiometric assay for the determination of AHH activity in lymphocytes is described. Subjects included eleven male patients with histologically verified lung cancer (nine squamous cell car-cinoma and two adenocarcinoma) and eleven age-and sex-matched controls. Lung cancer patients exhibited considerably greater varia-tion and elevated levels of both AHH activity per se and AHH activity adjusted for total cellular DNA than control individuals. Methodology for AHH determinations and implications for lung cancer epidemiology and control are discussed.

Original language	English (US)
Pages (from-to)	105-109
Number of pages	5
Journal	Oncology (Switzerland)
Volume	33
Issue number	3
DOIs	https://doi.org/10.1159/000225116
State	Published - 1976

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1159/000225116

Fingerprint Dive into the research topics of 'Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls'. Together they form a unique fingerprint.

Cite this

@article{9434ee76a5f24fc8b11c5713c0aff61a,

title = "Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls",

abstract = "A radiometric assay for the determination of AHH activity in lymphocytes is described. Subjects included eleven male patients with histologically verified lung cancer (nine squamous cell car-cinoma and two adenocarcinoma) and eleven age-and sex-matched controls. Lung cancer patients exhibited considerably greater varia-tion and elevated levels of both AHH activity per se and AHH activity adjusted for total cellular DNA than control individuals. Methodology for AHH determinations and implications for lung cancer epidemiology and control are discussed.",

author = "Guirgis, {H. A.} and Lynch, {H. T.} and T. Mate and Harris, {R. E.} and I. Wells and L. Caha and J. Anderson and K. Maloney and L. Rankin",

year = "1976",

doi = "10.1159/000225116",

language = "English (US)",

volume = "33",

pages = "105--109",

journal = "Oncology",

issn = "0030-2414",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls

AU - Guirgis, H. A.

AU - Lynch, H. T.

AU - Mate, T.

AU - Harris, R. E.

AU - Wells, I.

AU - Caha, L.

AU - Anderson, J.

AU - Maloney, K.

AU - Rankin, L.

PY - 1976

Y1 - 1976

N2 - A radiometric assay for the determination of AHH activity in lymphocytes is described. Subjects included eleven male patients with histologically verified lung cancer (nine squamous cell car-cinoma and two adenocarcinoma) and eleven age-and sex-matched controls. Lung cancer patients exhibited considerably greater varia-tion and elevated levels of both AHH activity per se and AHH activity adjusted for total cellular DNA than control individuals. Methodology for AHH determinations and implications for lung cancer epidemiology and control are discussed.

AB - A radiometric assay for the determination of AHH activity in lymphocytes is described. Subjects included eleven male patients with histologically verified lung cancer (nine squamous cell car-cinoma and two adenocarcinoma) and eleven age-and sex-matched controls. Lung cancer patients exhibited considerably greater varia-tion and elevated levels of both AHH activity per se and AHH activity adjusted for total cellular DNA than control individuals. Methodology for AHH determinations and implications for lung cancer epidemiology and control are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0017056286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017056286&partnerID=8YFLogxK

U2 - 10.1159/000225116

DO - 10.1159/000225116

M3 - Article

C2 - 1012643

AN - SCOPUS:0017056286

VL - 33

SP - 105

EP - 109

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 3

ER -